• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对多囊卵巢综合征女性不孕治疗结局的影响。

The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome.

作者信息

Al-Azemi Majedah, Omu Florence E, Omu Alexander E

机构信息

Department of Obstetrics and Gynaecology, Faculty of Medicine, Kuwait University, Kuwait.

出版信息

Arch Gynecol Obstet. 2004 Dec;270(4):205-10. doi: 10.1007/s00404-003-0537-2. Epub 2003 Aug 29.

DOI:10.1007/s00404-003-0537-2
PMID:12955532
Abstract

INTRODUCTION

Obesity has become a worldwide epidemic with ever increasing incidence and public health problems in both developing and developed countries.

OBJECTIVE

The objective of the study is to investigate the incidence of obesity among patients with polycystic ovarian syndrome attending infertility clinic and the effect on treatment outcome.

METHODOLOGY

Two hundred and seventy women with polycystic ovarian syndrome attending the infertility clinic were evaluated clinically, biochemically, and laparoscopically. They were stratified according to their body mass index (BMI) as follows: normal weight: 18-24; overweight: 25-29, obese:30-34, and grossly obese: > or = 35. Therapy included induction of ovulation with clomiphene citrate and gonadotrophins. The patients were followed up through during induction of ovulation and pregnancy.

RESULTS

There were ethnic differences in mean BMI. Significantly more obese women had oligomenorrhoea (p<0.01) and anovulation (p<0.01) than women with normal weight. Obesity adversely affected the outcome of ovulation induction with clomiphene citrate and gonadotrophins; 79% of women with BMI 18-24 ovulated at 6 months compared to 15.3% in those with BMI 30-34 (p<0.001) and 11.8% in women with BMI > or = 35 (p<0.001). The pregnancy rate and outcome were also adversely affected by obesity.

CONCLUSION

Obesity has a negative impact on the outcome of treatment of infertility. Weight reduction programme should be an essential component of infertility management.

摘要

引言

肥胖已成为一种全球性的流行病,在发展中国家和发达国家的发病率及公共卫生问题都日益增加。

目的

本研究的目的是调查在不孕不育门诊就诊的多囊卵巢综合征患者中肥胖的发生率及其对治疗结局的影响。

方法

对270名在不孕不育门诊就诊的多囊卵巢综合征女性进行了临床、生化和腹腔镜评估。根据她们的体重指数(BMI)进行分层如下:正常体重:18 - 24;超重:25 - 29,肥胖:30 - 34,极度肥胖:≥35。治疗包括使用枸橼酸氯米芬和促性腺激素诱导排卵。在诱导排卵和妊娠期间对患者进行随访。

结果

平均BMI存在种族差异。与正常体重的女性相比,肥胖女性出现月经过少(p<0.01)和无排卵(p<0.01)的情况明显更多。肥胖对枸橼酸氯米芬和促性腺激素诱导排卵的结局产生不利影响;BMI为18 - 24的女性中有79%在6个月时排卵,而BMI为30 - 34的女性中这一比例为15.3%(p<0.001),BMI≥35的女性中为11.8%(p<0.001)。肥胖也对妊娠率和结局产生不利影响。

结论

肥胖对不孕不育治疗的结局有负面影响。减重计划应成为不孕不育管理的重要组成部分。

相似文献

1
The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome.肥胖对多囊卵巢综合征女性不孕治疗结局的影响。
Arch Gynecol Obstet. 2004 Dec;270(4):205-10. doi: 10.1007/s00404-003-0537-2. Epub 2003 Aug 29.
2
Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.评估一种治疗多囊卵巢综合征中克罗米芬抵抗性不孕的新手术方法:腹腔镜卵巢多针干预。
J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):355-8. doi: 10.1016/j.jmig.2005.05.017.
3
Ovulation induction management of PCOS.多囊卵巢综合征的促排卵管理
Clin Obstet Gynecol. 2007 Mar;50(1):255-67. doi: 10.1097/GRF.0b013e31802f361e.
4
The preconceptual contraception paradigm: obesity and infertility.孕前避孕模式:肥胖与不孕
Hum Reprod. 2007 Apr;22(4):912-5. doi: 10.1093/humrep/del473. Epub 2006 Dec 15.
5
Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome.比较二甲双胍和枸橼酸氯米酚治疗多囊卵巢综合征诱导排卵的疗效。
Arch Gynecol Obstet. 2010 Oct;282(4):439-43. doi: 10.1007/s00404-010-1497-y. Epub 2010 May 16.
6
The treatment of infertility in polycystic ovary syndrome: a brief update.多囊卵巢综合征不孕症的治疗:简要更新
Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):400-3. doi: 10.1111/j.1479-828X.2012.01448.x. Epub 2012 May 28.
7
Obstetric outcomes after in vitro fertilization in obese and morbidly obese women.肥胖和病态肥胖女性体外受精后的产科结局
Obstet Gynecol. 2006 Jul;108(1):61-9. doi: 10.1097/01.AOG.0000219768.08249.b6.
8
Evaluation and treatment of anovulatory and unexplained infertility.排卵障碍性和不明原因不孕的评估与治疗。
Obstet Gynecol Clin North Am. 2012 Dec;39(4):507-19. doi: 10.1016/j.ogc.2012.09.008.
9
Metformin in the treatment of clomiphene citrate-resistant women with high BMI and primary infertility: clinical results and reproductive outcome.二甲双胍治疗高BMI且原发性不孕的克罗米芬耐药女性:临床结果与生殖结局
J Obstet Gynaecol. 2005 Jan;25(1):55-9. doi: 10.1080/01443610400025382.
10
Consensus on infertility treatment related to polycystic ovary syndrome.多囊卵巢综合征相关不孕治疗的共识
Fertil Steril. 2008 Mar;89(3):505-22. doi: 10.1016/j.fertnstert.2007.09.041. Epub 2008 Feb 20.

引用本文的文献

1
Role of Granulosa Cell Dysfunction in Women Infertility Associated with Polycystic Ovary Syndrome and Obesity.颗粒细胞功能障碍在多囊卵巢综合征和肥胖相关女性不孕症中的作用。
Biomolecules. 2025 Jun 24;15(7):923. doi: 10.3390/biom15070923.
2
The impact of a group based, remotely delivered weight loss intervention in women with polycystic ovary syndrome on ovulation, quality of life and body composition.一项针对多囊卵巢综合征女性的基于群体、远程提供的减肥干预措施对排卵、生活质量和身体成分的影响。
Front Reprod Health. 2022 Jul 22;4:940945. doi: 10.3389/frph.2022.940945. eCollection 2022.
3
Ovulation induction techniques in women with polycystic ovary syndrome.
多囊卵巢综合征女性的促排卵技术
Front Med (Lausanne). 2022 Aug 12;9:982230. doi: 10.3389/fmed.2022.982230. eCollection 2022.
4
Characterization of polycystic ovary syndrome among Flo app users around the world.多囊卵巢综合征在 Flo 应用程序全球用户中的特征。
Reprod Biol Endocrinol. 2021 Mar 3;19(1):36. doi: 10.1186/s12958-021-00719-y.
5
Contribution of ADIPOQ Variants to the Genetic Susceptibility of Recurrent Pregnancy Loss.ADIPOQ 变异与复发性妊娠丢失的遗传易感性有关。
Reprod Sci. 2021 Jan;28(1):263-270. doi: 10.1007/s43032-020-00274-8. Epub 2020 Aug 3.
6
EFFECT OF INSULIN RESISTANCE ON THE OCCURRENCE OF PREGNANCY IN WOMEN TREATED EMPIRICALLY FOR UNEXPLAINED INFERTILITY.胰岛素抵抗对不明原因不孕症经验性治疗女性妊娠发生情况的影响
Acta Endocrinol (Buchar). 2017 Jul-Sep;13(3):314-321. doi: 10.4183/aeb.2017.314.
7
Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review.关于多囊卵巢综合征瘦型患者的争论:一项叙述性综述
J Hum Reprod Sci. 2017 Jul-Sep;10(3):154-161. doi: 10.4103/jhrs.JHRS_77_17.
8
Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study.体重指数对中国多囊卵巢综合征女性控制性卵巢刺激结局的影响:一项多中心、前瞻性、观察性研究。
J Assist Reprod Genet. 2017 Jan;34(1):61-70. doi: 10.1007/s10815-016-0830-1. Epub 2016 Nov 5.
9
Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China.中国多囊或非多囊卵巢综合征不孕患者辅助生殖治疗期间的最佳体重指数分析。
Sci Rep. 2016 Sep 30;6:34538. doi: 10.1038/srep34538.
10
Impact of obesity on infertility in women.肥胖对女性不孕症的影响。
J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):111-7. doi: 10.5152/jtgga.2015.15232. eCollection 2015.